In conclusion, the present study showed the expression of COL7A1 mRNA in PBMCs and the feasibility of using PBMCs to analyze the consequences of COL7A1 mutations in patients with DEB. The gene discussed is COL7A1; the disease is Dystrophic epidermolysis bullosa.